Ignite Creation Date:
2024-05-05 @ 12:03 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00235625
Status:
COMPLETED
Last Update Posted:
2007-12-17
First Post:
2005-10-06
Brief Title:
Curcuminoids for the Treatment of Chronic Psoriasis Vulgaris
Sponsor:
University of Pennsylvania
Organization:
University of Pennsylvania
Study Overview
Official Title:
A Phase II Open Label Study of the Safety and Efficacy of Curcuminoids C3 Complex in Patients With Chronic Psoriasis Vulgaris
Status:
COMPLETED
Status Verified Date:
2007-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Turmeric Curcuma Longa is member of the ginger family and is best known for its culinary use as the major of component of curry powder The volatile of oils called curcuminoids of the turmeric root however have anti-inflammatory actions which make them promising candidates for the treatment of psoriasis For example curcumin has been shown to improve psoriasis in experiments using in vitro models Turmeric has been shown to have minimal side effects in doses up to 12 grams per day The purpose of this study is to determine the safety and to estimate the efficacy of oral Curcuminoid C3 Complex in patients with chronic psoriasis vulgaris
Detailed Description:
This study is no longer recruiting
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None